Scholarlink

<p>Based on a&#xa0;patient’s risk factors, an early prostate-specific antigen (PSA) test is recommended as a&#xa0;cornerstone for a&#xa0;subsequent risk-adapted early detection strategy. It is essential to ensure that patients receive detailed information about their individual risk profile concerning diagnostic procedures and potential treatment outcomes. Additionally, employing multiparametric magnetic resonance imaging (mpMRI) strategically before a&#xa0;biopsy can improve diagnostic accuracy and should be standard of care [<CitationRef CitationID="CR1">1</CitationRef>].</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Prostate cancer—early individualized screening is key

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月20日

查看全文
  • Conrad Leitsmann,
  • Florian Trummer

摘要

Based on a patient’s risk factors, an early prostate-specific antigen (PSA) test is recommended as a cornerstone for a subsequent risk-adapted early detection strategy. It is essential to ensure that patients receive detailed information about their individual risk profile concerning diagnostic procedures and potential treatment outcomes. Additionally, employing multiparametric magnetic resonance imaging (mpMRI) strategically before a biopsy can improve diagnostic accuracy and should be standard of care [1].